Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis

被引:77
作者
David, Sascha [1 ]
Kuempers, Philipp [1 ]
Seidler, Vega [1 ]
Biertz, Frank [2 ]
Haller, Hermann [1 ]
Fliser, Danilo [1 ]
机构
[1] Hannover Med Sch, Dept Nephrol, D-30625 Hannover, Germany
[2] Hannover Med Sch, Inst Biometry & Stat, D-30625 Hannover, Germany
关键词
bioelectrical impedance analysis (BIA); chronic kidney disease (CKD); left ventricular dysfunction (LVD); maintenance haemodialysis (HD); N-terminal pro-B-type natriuretic peptide (NT-proBNP);
D O I
10.1093/ndt/gfm700
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Natriuretic peptides such as N-terminal pro-B-type natriuretic peptide (NT-proBNP) have become increasingly important in diagnosing left ventricular dysfunction (LVD), however, in patients with chronic kidney disease (CKD), their use is confounded by concomitant volume overload and reduced renal excretion. We hypothesized that a serum NT-proBNP cut-off value adjusted for patients with CKD could serve as a biochemical marker to detect LVD in patients on haemodialysis treatment regardless of chronic fluid overload. Methods. We assessed LV function using trans-thoracic echocardiography and indices of hydration status such as extracellular water (ECW) using bioelectrical impedance analysis (BIA) in 62 stable patients on maintenance haemodialysis. NT-proBNP cutoff values for LVD with different specificities and sensitivities were calculated by ROC curves. Results. We found a significant inverse correlation between LV ejection fraction (EF) and NT-proBNP levels (r = -0.77, P = 0.0001). In the multivariate regression analysis NT-proBNP was the only independent predictor of EF (r = 0.699, P = 0.0001). NT-proBNP levels were significantly higher (P < 0.0001) in patients with LVD (n = 15; 32 760 +/- 6605 ngL) compared to those without LVD (n = 47; 2835 +/- 428 ngL). An NT-proBNP cut-off value of 7168 ngL resulted in 90 specificity and 79% sensitivity for the presence of LVD, i.e. an EF <45% (AUC(ROC): 0.95 +/- 0.03, P < 0.0001). Furthermore, in patients with LVD we found a significant relationship between serum NT-proBNP and markers of fluid overload such as the ECWbody weight ratio (P < 0.0001) and the grade of peripheral oedema (P = 0.007), but not in patients without LVD. Conclusion. A serum NT-proBNP cut-off value of >= 7200 ngL discriminates CKD stage 5 patients without LVD from those with LVD. In those patients with LVD, persistent post-dialytic volume overload correlates with elevated NT-proBNP levels.
引用
收藏
页码:1370 / 1377
页数:8
相关论文
共 42 条
[1]   Higher New York Heart Association classes and increased mortality and hospitalization in patients with heart failure and preserved left ventricular function [J].
Ahmed, A ;
Aronow, WS ;
Fleg, JL .
AMERICAN HEART JOURNAL, 2006, 151 (02) :444-450
[2]   Enhancement of quality of life with adjustment of dry weight by echocardiographic measurement of inferior vena cava diameter in patients undergoing chronic hemodialysis [J].
Chang, ST ;
Chen, CL ;
Chen, CC ;
Lin, FC ;
Wu, D .
NEPHRON CLINICAL PRACTICE, 2004, 97 (03) :90-97
[3]  
Charra Bernard, 2007, Hemodial Int, V11, P21, DOI 10.1111/j.1542-4758.2007.00148.x
[4]  
Das Manisha, 2006, Cardiol Rev, V14, P14, DOI 10.1097/01.crd.0000148162.88296.9f
[5]   Pathophysiology of cardiovascular disease and renal failure [J].
Dikow, R ;
Zeler, M ;
Ritz, E .
CARDIOLOGY CLINICS, 2005, 23 (03) :311-+
[6]   Association between brain natriuretic peptide and extracellular water in hemodialysis patients [J].
Fagugli, RM ;
Palumbo, B ;
Ricciardi, D ;
Pasini, P ;
Santirosi, P ;
Vecchi, L ;
Pasticci, F ;
Palumbo, R .
NEPHRON CLINICAL PRACTICE, 2003, 95 (02) :C60-C66
[7]   Natriuretic peptides in the diagnosis and management of heart failure [J].
Felker, G. Michael ;
Petersen, John W. ;
Mark, Daniel B. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 175 (06) :611-617
[8]  
Foley RN, 1998, J AM SOC NEPHROL, V9, P267
[9]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[10]  
Foley RN, 1998, J NEPHROL, V11, P239